Cuu Long Pharmaceutical

DCL

VN000000DCL1

Pharmaceuticals

End-of-day quote Ho Chi Minh S.E. Other stock markets 06:00:00 2024-05-19 pm EDT			5-day change	1st Jan Change
30,100 ^VND	0.00%		+7.50%	+20.40%

Apr. 24	Cuu Long Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 05	Cuu Long Pharmaceutical Joint Stock Company Announces Management Resignations	CI

Cuu Long Pharmaceutical Joint Stock Company Announces Executive Changes

December 21, 2021 at 12:11 am EST

Cuu Long Pharmaceutical Joint Stock Company announced personnel change. The company approving the resignation of Mr. Vo Xuan Vinh as Deputy CEO in charge business as from January 01, 2022. Approving the appointment of Mr. Nguyen Ngoc Vinh as Deputy CEO in charge business as from December 17, 2021.

Latest news about Cuu Long Pharmaceutical

Cuu Long Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 24	CI
Cuu Long Pharmaceutical Joint Stock Company Announces Management Resignations	Apr. 05	CI
Cuu Long Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Jan. 29	CI
Cuu Long Pharmaceutical Joint Stock Company Reports Earnings Results for the Full Year Ended December 31, 2023	Jan. 29	CI
Cuu Long Pharmaceutical Joint Stock Company Announces Change in Personnel	23-10-23	CI
Cuu Long Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-07-27	CI
Cuu Long Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-26	CI
Cuu Long Pharmaceutical Joint Stock Company Announces the Resignation of Nghiem Xuan Truong as CFO	23-03-20	CI
Cuu Long Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-01-30	CI
Cuu Long Pharmaceutical Joint Stock Company Reports Earnings Results for the Full Year Ended December 31, 2022	23-01-30	CI
Cuu Long Pharmaceutical Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-10-28	CI
Cuu Long Pharmaceutical Joint Stock Company Announces Resignation of Luong Trong Hai as Director	22-09-06	CI
Cuu Long Pharmaceutical Joint Stock Company Announces CEO Changes	22-09-06	CI
Cuu Long Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-07-28	CI
Cuu Long Pharmaceutical Joint Stock Company Provides Earnings Guidance for the Fiscal Year 2022	22-06-16	CI
Cuu Long Pharmaceutical Joint Stock Company Announces Resignation of Nguyen Ngoc Vinh as Deputy CEO	22-05-05	CI
Cuu Long Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-28	CI
Cuu Long Pharmaceutical Joint Stock Company announced that it has received VND 355.20515 billion in funding	22-03-15	CI
Cuu Long Pharmaceutical Joint Stock Company Reports Earnings Results for the Full Year Ended December 31, 2021	22-01-20	CI
Cuu Long Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter Ended December 31, 2021	22-01-20	CI
Cuu Long Pharmaceutical Joint Stock Company Announces Executive Changes	22-01-04	CI
Cuu Long Pharmaceutical Joint Stock Company announced a financing transaction	21-12-28	CI
Cuu Long Pharmaceutical Joint Stock Company Announces Executive Changes	21-12-21	CI
Cuu Long Pharmaceutical Joint Stock Company Announces Suspension of Operation of Branches	21-12-17	CI
Benovas Medevices announced that it expects to receive VND 50 billion in funding from Cuu Long Pharmaceutical Joint Stock Company	21-12-12	CI

Chart Cuu Long Pharmaceutical

Duration

Period

More charts

Company Profile

Cuu Long Pharmaceutical Joint Stock Corporation (Pharimexco) is a Vietnam-based company engaged in the pharmaceutical industry. The Company manufactures, markets and distributes pharmaceutical drugs and capsules, as well as medical equipment and supplies. It is also involved in the manufacture and trading of functional food, cosmetic products, chemicals and other materials for pharmaceutical production. Other activities include the manufacture of specialized packagings for drugs and medical products, as well as the cultivation of traditional herbs.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
CUU LONG PHARMACEUTICAL	+20.40%	86.38M
ELI LILLY AND COMPANY	+34.35%	693B
NOVO NORDISK A/S	+29.39%	584B
JOHNSON & JOHNSON	-3.49%	372B
MERCK & CO., INC.	+20.15%	332B
ABBVIE INC.	+6.19%	294B
ASTRAZENECA PLC	+14.11%	239B
ROCHE HOLDING AG	-3.03%	211B
NOVARTIS AG	+10.02%	210B
AMGEN INC.	+9.21%	168B

Other Pharmaceuticals